Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

Columnist Desiree Lama explores how living with MS led her to confront the comparison trap, ultimately finding strength in ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Columnist Ben Hofmeister reveals how MS heat sensitivity now hinders his ability to fully enjoy summer activities.

Multiple sclerosis is the most prevalent chronic inflammatory disease of the central nervous system (CNS), affecting more than 2 million people worldwide (at least 400,000 in the United States), 1 ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay hidden before noticeable symptoms appear and the subtle early signs that ar ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Japan is expected to have the lowest count at 31,527 cases. The diagnosed prevalent cases of multiple sclerosis (MS) in the ...

Researchers in Gisborne are helping develop a new MRI scan method, which they say can detect subtle brain lesions in multiple ...

Multiple sclerosis is an uncommon disease, affecting nearly 3 million people globally. Yet Epstein-Barr virus is almost everywhere. The virus, discovered in 1964, infects an estimated 90 percent ...

Treatment Options for Multiple Sclerosis. This review focuses on the current knowledge of the pathogenesis of the inflammatory and neurodegenerative elements of the multiple sclerosis plaque. In ...